
Browsing restrictions can be lifted for a fee.
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers hard contact lenses under HiClear and Soclear brands; soft contact lenses under Brio+moist, iDealsoft, and MyOKvision names; contact lens care potion under the Oxy vision plus Briomoist and Mu likang brands; and other ancillary products, as well as night-wear orthokeratology hard contact lenses. Brighten Optix Corporation is based in Taipei, Taiwan.
6747
亨泰光
0.00%
(0.00)
The most recent financial report for 亨泰光 (6747) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6747's short-term business performance and financial health. For the latest updates on 6747's earnings releases, visit this page regularly.
According to historical valuation range analysis, 亨泰光 (6747)'s current price-to-earnings (P/E) ratio is 77.28, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 亨泰光 (6747) reported an Operating Profit of 54.51M with an Operating Margin of 25.13% this period, representing a decline of 18.04% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 亨泰光 (6747) announced revenue of 216.97M, with a Year-Over-Year growth rate of -5.45%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 亨泰光 (6747) held Total Cash and Cash Equivalents of 460.71M, accounting for 0.31 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 亨泰光 (6747) achieved the “three margins increasing” benchmark, with a gross margin of 68.7%%, operating margin of 25.13%%, and net margin of 26.24%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6747's profit trajectory and future growth potential.
According to the past four quarterly reports, 亨泰光 (6747)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.15. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
亨泰光 (6747)'s Free Cash Flow (FCF) for the period is 140.91M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 1,551.18% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.